headache relief
Generic: acetaminophen, aspirin, caffeine
Labeler: chain drug marketing association, inc.Drug Facts
Product Profile
Brand Name
headache relief
Generic Name
acetaminophen, aspirin, caffeine
Labeler
chain drug marketing association, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
acetaminophen 250 mg/1, aspirin 250 mg/1, caffeine 65 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
83324-063
Product ID
83324-063_b5d4aa6d-8be6-4162-8ee9-f81a1712ca6a
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M013
Listing Expiration
2026-12-31
Marketing Start
2025-06-19
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
83324063
Hyphenated Format
83324-063
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
headache relief (source: ndc)
Generic Name
acetaminophen, aspirin, caffeine (source: ndc)
Application Number
M013 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/1
- 65 mg/1
Packaging
- 1 BOTTLE, PLASTIC in 1 CARTON (83324-063-24) / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Packages (1)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b5d4aa6d-8be6-4162-8ee9-f81a1712ca6a", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0635515969858"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["ddbcf5d6-183b-4080-a788-e870b4f88590"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Chain Drug Marketing Association, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (83324-063-24) / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC", "package_ndc": "83324-063-24", "marketing_start_date": "20250619"}], "brand_name": "Headache Relief", "product_id": "83324-063_b5d4aa6d-8be6-4162-8ee9-f81a1712ca6a", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "83324-063", "generic_name": "Acetaminophen, Aspirin, Caffeine", "labeler_name": "Chain Drug Marketing Association, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Headache Relief", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20250619", "listing_expiration_date": "20261231"}